Annual CFF
$115.07 M
-$104.31 M-47.55%
31 December 2023
Summary:
IGM Biosciences annual cash flow from financing activities is currently $115.07 million, with the most recent change of -$104.31 million (-47.55%) on 31 December 2023. During the last 3 years, it has fallen by -$99.71 million (-46.43%). IGMS annual CFF is now -59.23% below its all-time high of $282.26 million, reached on 31 December 2019.IGMS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.20 M
+$586.00 K+95.28%
30 September 2024
Summary:
IGM Biosciences quarterly cash flow from financing activities is currently $1.20 million, with the most recent change of +$586.00 thousand (+95.28%) on 30 September 2024. Over the past year, it has dropped by -$43.44 million (-97.31%). IGMS quarterly CFF is now -99.47% below its all-time high of $224.65 million, reached on 30 September 2019.IGMS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.37 M
-$43.44 M-94.83%
30 September 2024
Summary:
IGM Biosciences TTM cash flow from financing activities is currently $2.37 million, with the most recent change of -$43.44 million (-94.83%) on 30 September 2024. Over the past year, it has dropped by -$112.78 million (-97.94%). IGMS TTM CFF is now -99.17% below its all-time high of $284.25 million, reached on 30 September 2019.IGMS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.5% | -97.3% | -97.9% |
| 3 y3 years | -46.4% | +12.1% | -98.9% |
| 5 y5 years | +415.1% | -99.5% | -99.2% |
IGMS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -47.5% | +4547.3% | -99.5% | +1568.1% | -98.9% | at low |
| 5 y | 5 years | -59.2% | +4547.3% | -99.5% | +160.2% | -99.2% | +175.9% |
| alltime | all time | -59.2% | +4547.3% | -99.5% | +160.2% | -99.2% | +175.9% |
IGM Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.20 M(+95.3%) | $2.37 M(-94.8%) |
| June 2024 | - | $615.00 K(+304.6%) | $45.81 M(-60.2%) |
| Mar 2024 | - | $152.00 K(-62.2%) | $115.14 M(+0.1%) |
| Dec 2023 | $115.07 M(-47.5%) | $402.00 K(-99.1%) | $115.07 M(-0.1%) |
| Sept 2023 | - | $44.64 M(-36.2%) | $115.15 M(+62.6%) |
| June 2023 | - | $69.95 M(>+9900.0%) | $70.81 M(-67.7%) |
| Mar 2023 | - | $75.00 K(-84.4%) | $219.38 M(+0.0%) |
| Dec 2022 | $219.38 M(+8760.3%) | $482.00 K(+62.3%) | $219.38 M(-0.5%) |
| Sept 2022 | - | $297.00 K(-99.9%) | $220.39 M(-0.3%) |
| June 2022 | - | $218.53 M(>+9900.0%) | $221.16 M(+8403.1%) |
| Mar 2022 | - | $72.00 K(-95.2%) | $2.60 M(+5.0%) |
| Dec 2021 | $2.48 M | $1.49 M(+39.2%) | $2.48 M(-98.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $1.07 M(-3345.5%) | $216.90 M(+0.9%) |
| June 2021 | - | -$33.00 K(-37.7%) | $214.91 M(+0.1%) |
| Mar 2021 | - | -$53.00 K(-100.0%) | $214.71 M(-0.0%) |
| Dec 2020 | $214.78 M(-23.9%) | $215.91 M(<-9900.0%) | $214.78 M(-6977.4%) |
| Sept 2020 | - | -$917.00 K(+291.9%) | -$3.12 M(-101.4%) |
| June 2020 | - | -$234.00 K(-1163.6%) | $222.44 M(-18.3%) |
| Mar 2020 | - | $22.00 K(-101.1%) | $272.25 M(-3.5%) |
| Dec 2019 | $282.26 M(+1163.6%) | -$1.99 M(-100.9%) | $282.26 M(-0.7%) |
| Sept 2019 | - | $224.65 M(+353.2%) | $284.25 M(+376.9%) |
| June 2019 | - | $49.57 M(+394.1%) | $59.60 M(+494.1%) |
| Mar 2019 | - | $10.03 M | $10.03 M |
| Dec 2018 | $22.34 M(+176.9%) | - | - |
| Dec 2017 | $8.07 M | - | - |
FAQ
- What is IGM Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for IGM Biosciences?
- What is IGM Biosciences annual CFF year-on-year change?
- What is IGM Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for IGM Biosciences?
- What is IGM Biosciences quarterly CFF year-on-year change?
- What is IGM Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for IGM Biosciences?
- What is IGM Biosciences TTM CFF year-on-year change?
What is IGM Biosciences annual cash flow from financing activities?
The current annual CFF of IGMS is $115.07 M
What is the all time high annual CFF for IGM Biosciences?
IGM Biosciences all-time high annual cash flow from financing activities is $282.26 M
What is IGM Biosciences annual CFF year-on-year change?
Over the past year, IGMS annual cash flow from financing activities has changed by -$104.31 M (-47.55%)
What is IGM Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of IGMS is $1.20 M
What is the all time high quarterly CFF for IGM Biosciences?
IGM Biosciences all-time high quarterly cash flow from financing activities is $224.65 M
What is IGM Biosciences quarterly CFF year-on-year change?
Over the past year, IGMS quarterly cash flow from financing activities has changed by -$43.44 M (-97.31%)
What is IGM Biosciences TTM cash flow from financing activities?
The current TTM CFF of IGMS is $2.37 M
What is the all time high TTM CFF for IGM Biosciences?
IGM Biosciences all-time high TTM cash flow from financing activities is $284.25 M
What is IGM Biosciences TTM CFF year-on-year change?
Over the past year, IGMS TTM cash flow from financing activities has changed by -$112.78 M (-97.94%)